Zuellig, multinationals blasted for hurting patients

Published: 2009-10-27 06:59:00

Updated: 2009-10-27 06:59:00

Local pharmacists and doctors has recently accused Zuellig Pharma Korea (ZPK) and foreign-invested pharmaceutical firms of undermining patient benefits by exploiting their powerful market position, calling their business activity a “virtual monopoly.’’

The Korean Pharmaceutical Association and...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK